• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Delaware Healthcare Fund

+ Add to Watchlist

DLRHX:US

20.95 USD 0.04 0.19%

As of 09:29:30 ET on 08/28/2014.

Snapshot for Delaware Healthcare Fund (DLRHX)

Year To Date: +16.91% 3-Month: +11.73% 3-Year: +29.25% 52-Week Range: 15.96 - 20.99
1-Month: +2.55% 1-Year: +30.73% 5-Year: - Beta vs RGUSH: 0.97

Mutual Fund Chart for DLRHX

No chart data available.
  • DLRHX:US 20.95
  • 1M
  • 1Y
Interactive DLRHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DLRHX

Delaware Healthcare Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize long-term capital growth through capital appreciation. The Fund invests at least 80% of its assets in the equity securities of health care companies.

Inception Date: 01-28-2010 Telephone: 1-800-523-1918
Managers: LIU-ER CHEN "NU"
Web Site: www.delawareinvestments.com/co/delaware

Fundamentals for DLRHX

NAV (on 2014-08-28) 20.95
Assets (M) (on 2014-08-28) 447.52
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for DLRHX

Dividend Type Short Term Cap Gain
Dividend Frequency Irreg
Last Dividend Net (on 2013-12-06) 0.32
Dividend Yield (ttm) 2.00

Fees & Expenses for DLRHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.50
Expense Ratio 1.63

Top Fund Holdings for DLRHX

Filing Date: 06/30/2014
Name Position Value % of Total
Eli Lilly & Co 555,000 34,504,350 8.415%
Teva Pharmaceutical Industries 430,000 22,540,600 5.497%
WellPoint Inc 200,000 21,522,000 5.249%
UCB SA 249,785 21,146,980 5.157%
Idenix Pharmaceuticals Inc 800,000 19,280,000 4.702%
Bristol-Myers Squibb Co 305,000 14,795,550 3.608%
Quest Diagnostics Inc 250,000 14,672,500 3.578%
Fresenius Medical Care AG & Co 207,600 13,954,142 3.403%
Chugai Pharmaceutical Co Ltd 488,300 13,760,021 3.356%
Boston Scientific Corp 1,050,000 13,408,500 3.270%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil